Four Roses Private Selection “Medicinal Whiskey”


Classification: Straight Bourbon

Company: Kirin Brewery Company

Distillery: Four Roses

Release Date: January 2021

Proof: 111.8

Age: 9 Years 7 Months

Mashbill: 60% Corn, 35% Rye, 5% Malted Barley

Color: Dark Gold

MSRP: $85 (2021)

Official Website


Rye spice | Light oak | Vanilla | Light leather | Spice rests on light and airy scents


Summer fruits | Vanilla | Rye spice | Cinnamon spice | Oak | Tobacco leaf | Leather | Nice mix of sweet, spicy, and earthy flavors


Oak | Bold spice | Vanilla | Earthy undertones | Leather | Lingering dry spice


Medicinal Whiskey is a pending 501(c)(3) nonprofit that has a mission of fighting childhood illness with the power and passion of whiskey enthusiasts. The organization is composed of approximately 120 doctors who raise funds from the barrels they pick to help sponsor the organization's two core charities: Duke Children’s Hospital and UNC Health Children’s Hospital. The goal is for the organization to benefit a different children’s hospital each quarter, with UVA Children’s Hospital being targeted for this April to June.

For their latest release, the group chose a single barrel of Four Roses with an OBSK recipe. Like their past barrel picks, this is a solid representation of a good Four Roses single barrel pick. The sip is approachable, and the fact that each bottle is benefiting a good cause, makes the sip that much better.

The bottle being reviewed comes from warehouse number KE barrel #63-3I.

The sample used for this review was provided to us at no cost courtesy its respective company. We thank them for allowing us to review it with no strings attached.
360 video

Written By: Jordan Moskal

April 22, 2021
photo of author
Available at these retailers
Four Roses Private Selection “Medicinal Whiskey”
Also Check out
No items found.
Reviews By This Author
Recent Reviews
Recent Articles
  • Exclusive Content
  • new content summary
  • bourbon in the news
  • social media roundup
Terms of UsePrivacy PolicyEthics PolicyCommenting Policy